Comments
Loading...
RAPT Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RAPT | Benzinga
RAPT Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.140
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of RAPT Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics | -$0.79 | -$0.14 | — | — | $0.00 | — | — | — | 05/12/2025 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.80 | -$0.34 | -$1.14 | -235.29% | $0.00 | — | $0.00 | — | 03/06/2025 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.82 | -$0.54 | -$0.47 | 12.96% | $0.00 | — | $0.00 | — | 11/12/2024 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.66 | -$0.72 | -$0.71 | 1.39% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.76 | -$0.81 | -$0.79 | 2.47% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.64 | -$0.86 | -$0.80 | 6.98% | $0.00 | — | $0.00 | — | 03/07/2024 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.63 | -$0.75 | -$0.82 | -9.33% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.62 | -$0.80 | -$0.66 | 17.50% | $886.00K | — | $0.00 | — | 08/11/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.69 | -$0.68 | -$0.76 | -11.76% | $641.00K | — | $0.00 | — | 05/11/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.61 | -$0.66 | -$0.64 | 3.03% | $756.00K | $220.00K | $0.00 | -100.00% | 03/14/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.63 | -$0.67 | -$0.63 | 5.97% | $966.00K | $340.00K | $0.00 | -100.00% | 11/10/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.63 | -$0.75 | -$0.62 | 17.33% | $869.00K | $280.00K | $886.00K | 216.43% | 08/11/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.66 | -$0.68 | -$0.69 | -1.47% | $1.22M | $220.00K | $641.00K | 191.36% | 05/11/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.52 | -$0.66 | -$0.61 | 7.58% | $1.30M | $700.00K | $756.00K | 8.00% | 03/10/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.60 | -$0.62 | -$0.63 | -1.61% | $1.53M | $780.00K | $966.00K | 23.85% | 11/10/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.51 | -$0.67 | -$0.63 | 5.97% | $1.28M | $950.00K | $869.00K | -8.53% | 08/11/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.56 | -$0.71 | -$0.66 | 7.04% | $0.00 | $870.00K | $1.22M | 40.46% | 05/11/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.87 | — | -$0.52 | — | $0.00 | — | $1.30M | — | 03/11/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$12.41 | — | -$0.60 | — | $0.00 | — | $1.53M | — | 11/16/2020 | Get Alert |
| RAPT | RAPT Therapeutics | — | — | -$0.51 | — | — | — | $1.28M | — | 08/13/2020 | Get Alert |
| RAPT | RAPT Therapeutics | -$13.28 | — | -$0.56 | — | — | — | $0.00 | — | 05/14/2020 | Get Alert |
RAPT Therapeutics (RAPT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $-1.14 | $-0.34 | -235.3 % |
| Q3 | 2024-11-12 | $-0.47 | $-0.54 | 13.0 % |
| Q2 | 2024-08-08 | $-0.71 | $-0.72 | 1.39 % |
| Q1 | 2024-05-09 | $-0.79 | $-0.81 | 2.47 % |
RAPT Therapeutics (RAPT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2023-03-14 | $0 | $220.00K | -100.0 % |
| Q3 | 2022-11-10 | $0 | $340.00K | -100.0 % |
| Q2 | 2022-08-11 | $886.00K | $280.00K | 216.4 % |
| Q1 | 2022-05-11 | $641.00K | $220.00K | 191.4 % |
FAQ
When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?
RAPT Therapeutics (RAPT) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
What were the latest earnings per share (EPS) for RAPT Therapeutics (NASDAQ:RAPT)?
The Actual EPS was $-1.14, which missed the estimate of $-0.34.
What were RAPT Therapeutics’s (NASDAQ:RAPT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
